MaxiVAX
MaxiVAX and Minaris sign manufacturing deal for cell-based cancer immunotherapy
February 22, 2021Sales and Marketing Cancer, MaxiVAX, Minaris
MaxiVAX and Minaris Regenerative Medicine have entered into a manufacturing agreement for MVX-ONCO-2, a cell-based immunotherapy for the treatment of …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
